Globe Life (NYSE:GL) Given New $172.00 Price Target at Wells Fargo & Company

Key Points

• Wells Fargo raised its price target on Globe Life to $172 (from $171) and kept an "overweight" rating, implying roughly a 17.2% upside from the recent share price.
• Analysts collectively rate GL a Moderate Buy with an average price target of about $172.11, based on 2 "Strong Buy", 6 "Buy" and 3 "Hold" recommendations.
• Globe Life missed quarterly EPS estimates at $3.39 (vs. $3.44 expected) but set FY2026 guidance of 14.95–15.65 EPS; insiders sold about 82,807 shares (~$12M) in the last quarter.

Globe Life (NYSE:GL - Get Free Report) had its target price raised by analysts at Wells Fargo & Company from $171.00 to $172.00 in a report released on Friday,Benzinga reports. The brokerage presently has an "overweight" rating on the stock. Wells Fargo & Company's price objective points to a potential upside of 17.17% from the stock's current price.

GL has been the topic of a number of other research reports. Weiss Ratings downgraded Globe Life from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Monday, March 30th. Piper Sandler raised Globe Life to a "strong-buy" rating in a research note on Thursday, April 2nd. Truist Financial increased their target price on Globe Life from $158.00 to $180.00 and gave the company a "buy" rating in a research note on Friday, February 6th. Texas Capital raised Globe Life to a "strong-buy" rating in a research note on Wednesday, March 18th. Finally, TD Cowen reissued a "buy" rating on shares of Globe Life in a research note on Thursday, December 11th. Two research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $172.11.

Globe Life Price Performance

Shares of GL stock traded down $0.60 on Friday, reaching $146.80. The company's stock had a trading volume of 27,987 shares, compared to its average volume of 500,810. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.39. Globe Life has a 12-month low of $111.13 and a 12-month high of $152.71. The company has a market capitalization of $11.51 billion, a P/E ratio of 10.43 and a beta of 0.47. The stock's 50 day simple moving average is $142.25 and its 200-day simple moving average is $138.88.

Globe Life (NYSE:GL - Get Free Report) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $3.44 by ($0.05). Globe Life had a return on equity of 21.30% and a net margin of 19.37%.The business had revenue of $1.52 billion during the quarter, compared to analysts' expectations of $1.53 billion. During the same quarter last year, the business posted $3.14 EPS. The company's quarterly revenue was up 3.6% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. As a group, equities analysts predict that Globe Life will post 13.87 earnings per share for the current fiscal year.

Insider Activity at Globe Life

In other news, Director Mark A. Blinn sold 1,750 shares of the stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $147.91, for a total transaction of $258,842.50. Following the completion of the sale, the director directly owned 3,372 shares in the company, valued at approximately $498,752.52. This represents a 34.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Robert Edward Hensley sold 712 shares of the company's stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $142.59, for a total transaction of $101,524.08. Following the completion of the transaction, the executive vice president owned 8,580 shares of the company's stock, valued at $1,223,422.20. This trade represents a 7.66% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 82,807 shares of company stock valued at $12,041,286 in the last quarter. 2.11% of the stock is currently owned by company insiders.

Institutional Trading of Globe Life

Several large investors have recently bought and sold shares of GL. Mather Group LLC. bought a new stake in Globe Life during the 3rd quarter valued at approximately $28,000. CYBER HORNET ETFs LLC bought a new stake in Globe Life during the 2nd quarter valued at approximately $28,000. Hilton Head Capital Partners LLC bought a new stake in Globe Life during the 4th quarter valued at approximately $30,000. MUFG Securities EMEA plc bought a new stake in Globe Life during the 2nd quarter valued at approximately $31,000. Finally, Quent Capital LLC bought a new stake in Globe Life during the 3rd quarter valued at approximately $36,000. 81.61% of the stock is owned by institutional investors.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.